Metformin mitigates SASP secretion and LPS-triggered hyper-inflammation in Doxorubicin-induced senescent endothelial cells

Introduction: Doxorubicin (DOX), a chemotherapeutic drug, induces senescence and increases the secretion of senescence-associated secretory phenotype (SASP) in endothelial cells (ECs), which contributes to DOX-induced inflammaging. Metformin, an anti-diabetic drug, demonstrates senomorphic effects on different models of senescence. However, the effects of metformin on DOX-induced endothelial senescence have not been reported before. Senescent ECs exhibit a hyper-inflammatory response to lipopolysachharide (LPS). Therefore, in our current work, we identified the effects of metformin on DOX-induced endothelial senescence and LPS-induced hyper-inflammation in senescent ECs. Methods: ECs were treated with DOX ± metformin for 24 h followed by 72 h incubation without DOX to establish senescence. Effects of metformin on senescence markers expression, SA-β-gal activity, and SASP secretion were assessed. To delineate the molecular mechanisms, the effects of metformin on major signaling pathways were determined. The effect of LPS ± metformin was determined by stimulating both senescent and non-senescent ECs with LPS for an additional 24 h. Results: Metformin corrected DOX-induced upregulation of senescence markers and decreased the secretion of SASP factors and adhesion molecules. These effects were associated with a significant inhibition of the JNK and NF-κB pathway. A significant hyper-inflammatory response to LPS was observed in DOX-induced senescent ECs compared to non-senescent ECs. Metformin blunted LPS-induced upregulation of pro-inflammatory SASP factors. Conclusion: Our study demonstrates that metformin mitigates DOX-induced endothelial senescence phenotype and ameliorates the hyper-inflammatory response to LPS. These findings suggest that metformin may protect against DOX-induced vascular aging and endothelial dysfunction and ameliorate infection-induced hyper-inflammation in DOX-treated cancer survivors.

[1]  David M. Liebovitz,et al.  Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up , 2022, medRxiv.

[2]  B. Mueller,et al.  A Population-Based Study of the Long-Term Risk of Infections Associated With Hospitalization in Childhood Cancer Survivors , 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Beshay N. Zordoky,et al.  EA.hy926 Cells and HUVECs Share Similar Senescence Phenotypes but Respond Differently to the Senolytic Drug ABT-263 , 2022, Cells.

[4]  B. Cariou,et al.  Protection by metformin against severe Covid-19: An in-depth mechanistic analysis , 2022, Diabetes & Metabolism.

[5]  G. Xiao,et al.  Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms , 2022, Theranostics.

[6]  Jeong-Woo Park,et al.  Metformin alleviates ionizing radiation-induced senescence by restoring BARD1-mediated DNA repair in human aortic endothelial cells , 2022, Experimental Gerontology.

[7]  N. Zarghami,et al.  An update on mode of action of metformin in modulation of meta-inflammation and inflammaging , 2022, Pharmacological Reports.

[8]  D. Gutterman,et al.  Endothelial dysfunction as a complication of anti-cancer therapy. , 2022, Pharmacology & therapeutics.

[9]  Yanhua Qi,et al.  Metformin protects lens epithelial cells against senescence in a naturally aged mouse model , 2022 .

[10]  Beshay N. Zordoky,et al.  Cardiovascular ramifications of therapy-induced endothelial cell senescence in cancer survivors. , 2022, Biochimica et biophysica acta. Molecular basis of disease.

[11]  Mingxian Chen,et al.  Metformin suppresses vascular smooth muscle cell senescence by promoting autophagic flux , 2021, Journal of advanced research.

[12]  M. Arasu,et al.  Cholecalciferol and metformin protect against lipopolysaccharide-induced endothelial dysfunction and senescence by modulating sirtuin-1 and protein arginine methyltransferase-1. , 2021, European journal of pharmacology.

[13]  U. Galderisi,et al.  Proteomic and Biological Analysis of the Effects of Metformin Senomorphics on the Mesenchymal Stromal Cells , 2021, Frontiers in Bioengineering and Biotechnology.

[14]  T. Foster,et al.  Senescence-associated hyper-activation to inflammatory stimuli in vitro , 2021, Aging.

[15]  Chunmei Zhang,et al.  Metformin alleviates oxidative stress‐induced senescence of human lens epithelial cells via AMPK activation and autophagic flux restoration , 2021, Journal of cellular and molecular medicine.

[16]  A. Díaz,et al.  Metformin Enhances B Cell Function and Antibody Responses of Elderly Individuals With Type-2 Diabetes Mellitus , 2021, Frontiers in Aging.

[17]  J. Dai,et al.  Matrix Metalloproteinase 3: A Promoting and Destabilizing Factor in the Pathogenesis of Disease and Cell Differentiation , 2021, Frontiers in Physiology.

[18]  H. Zitzelsberger,et al.  Metformin Protects against Radiation-Induced Acute Effects by Limiting Senescence of Bronchial-Epithelial Cells , 2021, International journal of molecular sciences.

[19]  N. LeBrasseur,et al.  Senolytics reduce coronavirus-related mortality in old mice , 2021, Science.

[20]  Zubair I Shah,et al.  Vitamin D3 attenuates doxorubicin-induced senescence of human aortic endothelial cells by upregulation of IL-10 via the pAMPKα/Sirt1/Foxo3a signaling pathway , 2021, PloS one.

[21]  Pian-pian Huang,et al.  Redd1 knockdown prevents doxorubicin-induced cardiac senescence , 2021, Aging.

[22]  S. Melov,et al.  Cellular senescence mediates doxorubicin‐induced arterial dysfunction via activation of mitochondrial oxidative stress and the mammalian target of rapamycin , 2021, The FASEB Journal.

[23]  J. Klimas,et al.  Vildagliptin improves vascular smooth muscle relaxation and decreases cellular senescence in the aorta of doxorubicin-treated rats. , 2021, Vascular pharmacology.

[24]  O. Carnevali,et al.  Anti-SASP and anti-inflammatory activity of resveratrol, curcumin and β-caryophyllene association on human endothelial and monocytic cells , 2021, Biogerontology.

[25]  C. Pinto,et al.  Cumulative COVID‐19 incidence, mortality and prognosis in cancer survivors: A population‐based study in Reggio Emilia, Northern Italy , 2020, International journal of cancer.

[26]  Xiaoli Cui,et al.  Metformin attenuates lipopolysaccharide‐induced epithelial cell senescence by activating autophagy , 2020, Cell biology international.

[27]  L. Niedernhofer,et al.  Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence. , 2020, Pharmacology & therapeutics.

[28]  Xuechu Zhen,et al.  Protective Effect of Metformin against Hydrogen Peroxide-Induced Oxidative Damage in Human Retinal Pigment Epithelial (RPE) Cells by Enhancing Autophagy through Activation of AMPK Pathway , 2020, Oxidative medicine and cellular longevity.

[29]  Jae-Seon Lee,et al.  Endothelial cells under therapy-induced senescence secrete CXCL11, which increases aggressiveness of breast cancer cells. , 2020, Cancer letters.

[30]  Brian R. Kotajarvi,et al.  The senescence-associated secretome as an indicator of age and medical risk. , 2020, JCI insight.

[31]  E. Fuentes,et al.  Platelet Activation Is Triggered by Factors Secreted by Senescent Endothelial HMEC-1 Cells In Vitro , 2020, International journal of molecular sciences.

[32]  S. Berger,et al.  Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence , 2020, Genes & development.

[33]  P. Robbins,et al.  Tissue specificity of senescent cell accumulation during physiologic and accelerated aging of mice , 2020, Aging cell.

[34]  P. Soysal,et al.  Inflammation, Frailty and Cardiovascular Disease. , 2020, Advances in experimental medicine and biology.

[35]  John D Lambris,et al.  Frailty and Cardiovascular Diseases: Research into an Elderly Population , 2020 .

[36]  I. Nagaoka,et al.  Bacterial lipopolysaccharide and antimicrobial LL-37 enhance ICAM-1 expression and NF-κB p65 phosphorylation in senescent endothelial cells , 2019, International journal of molecular medicine.

[37]  J. Sowers,et al.  Endothelial cell senescence in aging-related vascular dysfunction. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[38]  Kotb Abdelmohsen,et al.  Transcriptome signature of cellular senescence. , 2019, Nucleic acids research.

[39]  K. Ness,et al.  Premature Aging in Young Cancer Survivors. , 2019, Journal of the National Cancer Institute.

[40]  T. Minamino,et al.  Vascular Senescence in Cardiovascular and Metabolic Diseases , 2018, Front. Cardiovasc. Med..

[41]  J. Mar,et al.  Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults , 2018, Aging cell.

[42]  Chin-Shang Li,et al.  Investigation of quercetin and hyperoside as senolytics in adult human endothelial cells , 2018, PloS one.

[43]  A. Ballestrero,et al.  5‐fluorouracil causes endothelial cell senescence: potential protective role of glucagon‐like peptide 1 , 2017, British journal of pharmacology.

[44]  P. Robbins,et al.  New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463 , 2017, Aging.

[45]  D. Pascual-Figal,et al.  Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes , 2017, PloS one.

[46]  B. Kennedy,et al.  Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse. , 2017, Cancer discovery.

[47]  D. Seals,et al.  Dietary rapamycin supplementation reverses age‐related vascular dysfunction and oxidative stress, while modulating nutrient‐sensing, cell cycle, and senescence pathways , 2016, Aging cell.

[48]  S. Kritchevsky,et al.  Metformin as a Tool to Target Aging. , 2016, Cell metabolism.

[49]  P. Ye,et al.  Metformin Protects H9C2 Cardiomyocytes from High-Glucose and Hypoxia/Reoxygenation Injury via Inhibition of Reactive Oxygen Species Generation and Inflammatory Responses: Role of AMPK and JNK , 2016, Journal of diabetes research.

[50]  Yongjian Wu,et al.  Metformin and Resveratrol Inhibited High Glucose-Induced Metabolic Memory of Endothelial Senescence through SIRT1/p300/p53/p21 Pathway , 2015, PloS one.

[51]  P. Nelson,et al.  MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation , 2015, Nature Cell Biology.

[52]  Dolores Diaz,et al.  Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy , 2015, Science Translational Medicine.

[53]  Haiyan Zhang,et al.  Inhibitory effects of quercetagetin 3,4′-dimethyl ether purified from Inula japonica on cellular senescence in human umbilical vein endothelial cells , 2015, Archives of pharmacal research.

[54]  J. Dyck,et al.  The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention. , 2014, Biochimica et biophysica acta.

[55]  S. Samuel,et al.  Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1 , 2013, British journal of pharmacology.

[56]  G. Ferbeyre,et al.  Metformin inhibits the senescence‐associated secretory phenotype by interfering with IKK/NF‐κB activation , 2013, Aging cell.

[57]  A. Kusch,et al.  Recovery of senescent endothelial cells from injury. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[58]  E. Yeh,et al.  Identification of the molecular basis of doxorubicin-induced cardiotoxicity , 2012, Nature Medicine.

[59]  A. Salminen,et al.  Emerging role of NF-κB signaling in the induction of senescence-associated secretory phenotype (SASP). , 2012, Cellular signalling.

[60]  N. LeBrasseur,et al.  Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders , 2011, Nature.

[61]  F. Frassoni,et al.  p38 MAPK and JNK Antagonistically Control Senescence and Cytoplasmic p16INK4A Expression in Doxorubicin-Treated Endothelial Progenitor Cells , 2010, PloS one.

[62]  Norman Honbo,et al.  Doxorubicin Cardiomyopathy , 2009, Cardiology.

[63]  C. Barisione,et al.  Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2. , 2009, American journal of physiology. Heart and circulatory physiology.

[64]  M. Miura,et al.  Enhanced adhesion of early endothelial progenitor cells to radiation-induced senescence-like vascular endothelial cells in vitro. , 2009, Journal of radiation research.

[65]  Judith Campisi,et al.  Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor , 2008, PLoS biology.

[66]  C. Tse,et al.  ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. , 2008, Cancer research.

[67]  Kunihiro Suzuki,et al.  Metformin Inhibits Cytokine-Induced Nuclear Factor &kgr;B Activation Via AMP-Activated Protein Kinase Activation in Vascular Endothelial Cells , 2006, Hypertension.

[68]  C. Franceschi,et al.  Inflamm‐aging: An Evolutionary Perspective on Immunosenescence , 2000 .